Post Study Access of CSL312 (Garadacimab) for Pediatric Participants With Hereditary Angioedema Who Have Completed the CSL312_3003 Study
Clinical trial NCT07159464 · AVAILABLE
Trial details
- NCT number
- NCT07159464
- Sponsor
- CSL Behring
- Status
- AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.